Thermo Fisher Scientific | TMO - Gewinn Vor Steuern

Aktienkurs
498.87
Täglich Wechseln
-1.92 -0.38%
Monatlich
-0.24%
Jährlich
16.71%
Q2 Prognose
476.67




Gewinn Vor Steuern Veränderung Datum
Abbott USD 2.36B 178M 2025-12
Agilent USD 442M 1000K 2025-09
Becton, Dickinson and Co. USD 393M 117M 2025-12
Bio Techne USD 84.99M 107.85M 2025-09
Bio-Rad Laboratories USD 82.9M 331.1M 2025-09
Boston Scientific USD 938M 3M 2025-09
Bruker USD -72.6M 73.1M 2025-09
Charles River Laboratories USD 170.03M 98.62M 2025-09
Danaher USD 1.08B 421M 2025-09
Dentsply International USD -230M 77M 2025-09
Edwards Lifesciences USD 348.4M 51.8M 2025-09
General Electric Aerospace USD 2.85B 337M 2025-12
Henry Schein USD 137M 16M 2025-09
Hologic USD 229.7M 2.3M 2025-12
Illumina USD 220M 86M 2025-09
Intuitive Surgical USD 855.2M 23.1M 2025-09
IQVIA Holdings USD 6.16B 5.84B 2025-09
Laboratory Of America USD 337M 32.3M 2025-09
Medtronic USD 2.1B 224M 2025-09
Mettler Toledo International USD 269.24M 20.58M 2025-09
Myriad Genetics USD 4.6M 3.4M 2025-12
Olympus JPY 22.13B 5.77B 2025-12
OraSure Technologies USD -18.43M 5.14M 2025-12
Quest Diagnostics USD 336M 57M 2025-09
Repligen USD 17.11M 10.25M 2025-09
Revvity USD 55.68M 115.97M 2025-09
Stryker USD 1.03B 13M 2025-09
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Veracyte USD 40.63M 21.74M 2025-12
Waters USD 170.12M 7.57M 2025-09
Zimmer Biomet Holdings USD 418.7M 194.1M 2025-09